(Q43663434)

25 November 2017

title

Thalidomide neuropathy in patients treated for metastatic prostate cancer (English)

1 reference

25 November 2017

0 references

Molloy FM

1

1 reference

25 November 2017

Floeter MK

2

1 reference

25 November 2017

Syed NA

3

1 reference

25 November 2017

Sandbrink F

4

1 reference

25 November 2017

Culcea E

5

1 reference

25 November 2017

Steinberg SM

6

1 reference

25 November 2017

Dahut W

7

1 reference

25 November 2017

Pluda J

8

1 reference

25 November 2017

Kruger EA

9

1 reference

25 November 2017

Reed E

10

1 reference

25 November 2017

Figg WD

11

1 reference

25 November 2017

publication date

1 August 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

24

1 reference

25 November 2017

issue

8

1 reference

25 November 2017

page(s)

1050-1057

1 reference

2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients

25 November 2017

cites work

1 reference

Prurigo nodularis and photosensitivity in AIDS: Treatment with thalidomide

21 January 2018

1 reference

Inter- and intra-examiner reliability of nerve conduction measurements in normal subjects

21 January 2018

1 reference

Thalidomide neurotoxicity

21 January 2018

1 reference

A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold.

21 January 2018

1 reference

Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas

21 January 2018

1 reference

Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study

21 January 2018

1 reference

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy

21 January 2018

1 reference

Thalidomide-induced neuropathy and genetic differences in drug metabolism

21 January 2018

1 reference

Thalidomide-induced peripheral neuropathy. A prospective clinical, neurophysiological and pharmacogenetic evaluation

21 January 2018

1 reference

Thalidomide neuropathy: an electrophysiologic study

21 January 2018

1 reference

Clinical trials for polyneuropathy: the role of nerve conduction studies, quantitative sensory testing, and autonomic function testing

21 January 2018

1 reference

Guideline for the clinical use and dispensing of thalidomide

21 January 2018

1 reference

Thalidomide neuropathy: role of F-wave monitoring

21 January 2018

1 reference

The treatment of lepra reaction in lepromatous leprosy. Fifteen years' experience with thalidomide

21 January 2018

1 reference

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

Development of polyneuropathy during thalidomide therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.1109

1 reference

25 November 2017

1 reference